Pseudoword Learning for Aphasia
Trial Summary
What is the purpose of this trial?
Patients with stroke frequently suffer from aphasia, a disorder of expressive and/or receptive language, that can lead to serious health consequences, including social isolation, depression, reduced quality of life, and increased caregiver burden. Aphasia recovery varies greatly between individuals, and likely relies upon the capacity for neuroplasticity, both at a systems level of reorganized brain networks and a molecular level of neuronal repair and plasticity. The proposed work will evaluate genetic and neural network biological markers of neuroplasticity associated with variability in aphasia, with a future goal to improve prognostics and identify therapeutic targets to reduce the long-term burdens of aphasia.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that standard stroke treatments like Plavix, aspirin, beta-blockers, diabetes medications, cholesterol-lowering agents, thrombolytics, and anticoagulation agents are allowed.
What data supports the effectiveness of the Pseudoword learning paradigm task treatment for aphasia?
Research shows that people with aphasia can still learn new words, and this ability is linked to better treatment outcomes. A study found that training with pseudowords (made-up words) helped participants learn and remember new words, similar to how children learn language, suggesting this method could be effective for language recovery in aphasia.12345
Is pseudoword learning safe for humans?
How does the Pseudoword learning paradigm task treatment for aphasia differ from other treatments?
The Pseudoword learning paradigm task is unique because it uses a method similar to how children learn their first words, by pairing made-up words with objects and reinforcing correct pairings over multiple sessions. This approach focuses on re-acquiring language skills through associative learning, which is different from other treatments that may focus on specific word retrieval or error correction strategies.24578
Research Team
Haley Dresang, PhD
Principal Investigator
University of Wisconsin, Madison
Eligibility Criteria
This trial is for individuals aged 40-90 who have had a single ischemic stroke in the middle cerebral artery territory, resulting in aphasia. They must be right-handed (before the stroke), proficient in English, and able to consent. The study includes those with recent strokes for one part and those within 12 months post-stroke for other parts. Exclusions include significant vision/hearing loss, non-standard stroke treatments, other major medical/neurological disorders, uncontrolled psychiatric issues, or substance abuse.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a word-learning task for aphasia, including 210 trials across 7 learning blocks, with assessments of semantic, phonological, and verb processing abilities
Follow-up
Participants are monitored for changes in language abilities and neuroplasticity biomarkers post-stroke
Long-term follow-up
Participants' aphasia recovery and neuroplasticity biomarkers are evaluated to support future multi-site studies
Treatment Details
Interventions
- Pseudoword learning paradigm task
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator